USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
11 Mar 2025 | 04:00 PM GMT

Enhancing Clinical Impact Through Collaboration With Health Plans & PBMs

Anchored by:

Emily Judge
VP, Market Access & Strategic Partnerships
AXENA HEALTH

Participants:

Emily Judge VP, Market Access & Strategic PartnershipsAxena Health
Emily Judge
VP, Market Access & Strategic PartnershipsAxena Health
Lani Reilly VP Patient AccessDigital Therapeutics Alliance
Lani Reilly
VP Patient AccessDigital Therapeutics Alliance
Galyn Damiani AVP Virtual Care InstituteVCU Health
Galyn Damiani
AVP Virtual Care InstituteVCU Health
Lisa Suennen Managing Partner, AHA VenturesLisa Suennen
Lisa Suennen
Managing Partner, AHA VenturesLisa Suennen
Luke Pawley Customer Success ManagerHLTH Community
Luke Pawley
Customer Success ManagerHLTH Community
Maja Mazur CEOHealthnix
Maja Mazur
CEOHealthnix
Nele Jacobs CEOFaresa
Nele Jacobs
CEOFaresa
Rajan Gupta VP Technology and ProductsMercalis
Rajan Gupta
VP Technology and ProductsMercalis
SB
sidney brogan Market Access AssociateBeaconOne Healthcare Partners
SB
sidney brogan
Market Access AssociateBeaconOne Healthcare Partners

About this Meeting

The healthcare landscape is rapidly evolving, with digital therapeutics emerging as a crucial component in improving patient outcomes. As we explore the intersection of innovative therapeutic solutions with traditional healthcare infrastructure, collaboration between health plans, PBMs, and digital therapeutics companies becomes increasingly vital for delivering meaningful clinical results.

Join us to discuss:

  • Understanding the unique perspectives and priorities of health plans and PBMs in evaluating and implementing digital therapeutic solutions, including their focus on evidence-based outcomes and cost-effectiveness measures.
  • Exploring successful partnership models that have effectively integrated digital therapeutics into existing healthcare delivery systems, while addressing key challenges around implementation, reimbursement, and patient access.